What’s Going On With XPeng (XPEV) Stock Thursday?

XPeng Inc – ADR (NYSE: XPEV) shares are trading higher by 8.3% to $16.78 Thursday morning, despite a lack of company-specific news for the session.

XPeng Inc – ADR (NYSE:XPEV) shares are trading higher by 8.3% to $16.78 Thursday morning, despite a lack of company-specific news for the session. The company on Wednesday provided a delivery update. The stock may also be trading higher amid overall market strength following Wednesday’s Federal Reserve decision.

What Happened With XPEV Deliveries?

XPeng announced that it achieved a record high in vehicle deliveries for October 2023, with 20,002 Smart EVs delivered, marking a 31% increase from the previous month and a 292% increase compared to the previous year. The company says this continued growth momentum has been consistent for nine consecutive months.

Additionally, the production output of the XPENG G6 also increased significantly, resulting in 8,741 units delivered, making it the best-selling battery electric SUV in the RMB 200,000-250,000 price range.

See Also: What’s Going On With Nio Stock Thursday?

What Else?

During its 2023 Tech Day event on October 24, XPeng unveiled its go-to-market plan for its advanced driver-assistance system (ADAS) called XNGP, with plans to expand its deployment in 50 cities by year-end.

They also introduced a new ADAS feature called AI Valet Driver, which will be available for select customers by the end of 2023 and aims for nationwide coverage in 2024.

According to data from Benzinga Pro, XPEV has a 52-week high of $23.62 and a 52-week low of $6.40.

Total
0
Shares
Related Posts
Read More

Best Buy Sees Q2 2023 Comp Sales -13%

The company expects Q2 FY23 comparable sales1 to decline approximately 13%, with revenue approximately 7.5% higher than pre-pandemic Q2 FY20. This comparesThe company expects Q2 FY23 comparable sales1 to decline approximately 13%, with revenue approximately 7.5% higher than pre-pandemic Q2 FY20.

BBY

Read More

IM Cannabis’ Q4 Revenue: Gross Profit Drops Due To Negative Impact Of Israel-Hamas War, Sees Germany As Growth Opportunity

IM Cannabis Corp. (NASDAQ: IMCC) (CSE: IMCC) announced on Thursday its financial and operational results for the year ended Dec. 2023. The Toronto-headquartered medical cannabis company with a focus on Israel and Germany reported a 10% year-over-year decrease in revenue to CA$48.8 million ($36 million) in 2023. IM Cannabis attributed it to "negative currency fluctuations and the impact of the Israel-Hamas war on the company's operations." Fourth quarter revenue dropped 26% year-over-year to CA$10.7 million. "As previously warned and as expected, unfortunately, the Israel-Hamas war had a negative impact on our fourth quarter 2023 results, which weighed on our full-year results.," Uri Birenberg, chief financial officer of IMC, said. "Coupled with our fourth quarter of 2023 inventory reduction, the war caused our fourth quarter gross profit to decrease by 68% as compared to the fourth quarter of 2022."

CSE:IMCC